PRTA
Prothena Corp. Plc
NASDAQ · Healthcare · Biotechnology · IE
$8.58
+1.42%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.38
- Revenue estimate
- $9.6M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.32
- EPS estimate
- -$0.39
- Revenue actual
- $1.0M
- Revenue estimate
- $421.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.1%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.39 | -$0.32 | Beat 17.95% | $1.0M |
| May 7, 2026 | -$0.31 | $0.52 | Beat 267.74% | — |
| Feb 19, 2026 | -$0.45 | -$0.44 | Beat 2.22% | — |
| Nov 6, 2025 | -$0.60 | -$0.67 | Miss -11.67% | $2.4M |
| May 8, 2025 | -$0.92 | -$1.12 | Miss -21.74% | $2.8M |
| Feb 20, 2025 | -$1.02 | -$1.08 | Miss -5.88% | $2.1M |
| Aug 8, 2024 | -$1.05 | $1.22 | Beat 216.19% | $132.0M |
| Feb 15, 2024 | -$1.23 | -$1.26 | Miss -2.44% | $316.0K |
| Nov 2, 2023 | -$0.32 | $0.38 | Beat 218.75% | $84.9M |
| Aug 3, 2023 | -$0.92 | -$1.03 | Miss -11.96% | $4.0M |
| May 4, 2023 | -$0.83 | -$0.89 | Miss -7.23% | $2.2M |
| Feb 23, 2023 | -$0.47 | $0.12 | Beat 125.53% | $49.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026